Shimomura I, Bashmakov Y, Shimano H, Horton J D, Goldstein J L, Brown M S
Department of Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Room L5.238, Dallas, TX 75235-9046, USA.
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12354-9. doi: 10.1073/pnas.94.23.12354.
Cholesterol feeding reduces the mRNAs encoding multiple enzymes in the cholesterol biosynthetic pathway and the low density lipoprotein receptor in livers of hamsters. Here we show that cholesterol feeding also reduces the levels of the nuclear NH2-terminal domains of sterol regulatory element binding proteins (SREBPs), which activate transcription of sterol-regulated genes. We show that livers of hamsters, like those of mice and humans, predominantly produce SREBP-2 and the 1c isoform of SREBP-1. Both are produced as membrane-bound precursors that must be proteolyzed to release the transcriptionally active NH2-terminal domains. Diets containing 0.1% to 1.0% cholesterol decreased the amount of nuclear SREBP-1c without affecting the amount of the membrane precursor or its mRNA, suggesting that cholesterol inhibits the proteolytic processing of SREBP-1 in liver as it does in cultured cells. Cholesterol also appeared to reduce the proteolytic processing of SREBP-2. In addition, at high levels of dietary cholesterol the mRNA encoding SREBP-2 declined and the amount of the precursor also fell, suggesting that cholesterol accumulation also may inhibit transcription of the SREBP-2 gene. The high-cholesterol diets reduced the amount of low density lipoprotein receptor mRNA by 30% and produced a more profound 70-90% reduction in mRNAs encoding 3-hydroxy-3-methylglutaryl CoA synthase and reductase. Treatment with lovastatin and Colestipol, which increases hepatic demands for cholesterol, increased the amount of SREBP-2 mRNA as well as the precursor and nuclear forms of the protein. This treatment caused a reciprocal decline in SREBP-1c mRNA and protein. Considered together, these data suggest that SREBPs play important roles in controlling transcription of sterol-regulated genes in liver, as they do in cultured cells.
用胆固醇喂养可降低仓鼠肝脏中胆固醇生物合成途径中多种酶以及低密度脂蛋白受体的编码mRNA水平。在此我们表明,用胆固醇喂养还会降低固醇调节元件结合蛋白(SREBPs)的核氨基末端结构域水平,这些蛋白可激活固醇调节基因的转录。我们发现,仓鼠的肝脏与小鼠和人类的肝脏一样,主要产生SREBP-2和SREBP-1的1c异构体。两者均作为膜结合前体产生,必须经过蛋白水解才能释放出具有转录活性的氨基末端结构域。含0.1%至1.0%胆固醇的饮食可降低核SREBP-1c的量,而不影响膜前体的量或其mRNA水平,这表明胆固醇在肝脏中如同在培养细胞中一样,会抑制SREBP-1的蛋白水解加工过程。胆固醇似乎还会降低SREBP-2的蛋白水解加工过程。此外,在高胆固醇饮食水平下,编码SREBP-2的mRNA水平下降,前体的量也减少,这表明胆固醇积累也可能抑制SREBP-2基因的转录。高胆固醇饮食可使低密度脂蛋白受体mRNA的量减少30%,并使编码3-羟基-3-甲基戊二酰辅酶A合酶和还原酶mRNA水平更显著地降低70%-90%。用洛伐他汀和考来替泊进行治疗可增加肝脏对胆固醇的需求,增加SREBP-2 mRNA的量以及该蛋白的前体和核形式。这种治疗导致SREBP-1c mRNA和蛋白水平相应下降。综合来看,这些数据表明,SREBPs在肝脏中如同在培养细胞中一样,在控制固醇调节基因的转录方面发挥着重要作用。